The OFA filed a similar lawsuit last year when the FDA determined that Eli Lilly's (LLY) GLP-1 drug tirzepatide, also known as Mounjaro and Zepbound, was no longer in short supply. Earlier Monday ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback